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Effects of PBBs on Cattle. IV. Distribution
and Clearance of Components of
FireMaster BP-6
by L. B. Willett* and H. 1. Durst*
Sixty dairy animals were utilized in seven experiments to determine aspects of the distribution and
clearance of FireMaster BP-6. Experimental protocols of various studies provided daily exposures from
0.25 to25,000 mg, exposures for I to202days, and totalstudy periods from 10 to 1100 days. Necropsy of28
animals provided information on residue concentrations in 35 tissues, and the excretion in milk was
determined in 15 animals. These studies showed that the major brominated biphenyls of this commercial
mixture were absorbed from the gastrointestinal tract and appeared in the blood plasma within4 hr. With
continued exposure to the residue plasma concentrations reached a steady state by 15 days. Free PBB was
not detectable in urine. During PBB feeding feces was the major route of excretion, representing ap-
proximately 50%o of the amount fed to animals not displaying signs of toxicosis. Following withdrawal of
PBB, fecal concentrations declined to 1 to 2% of concentrations during dosing, yet, feces remained the
major excretory route in nonlactating animals. In contrast, in post-exposure lactating animals milk fat
became an important excretory route removing three-times the quantity of residue cleared in feces.
Following parturition, concentrations of PBB in milk fat declined approximately twofold in 6 days.
Thereafter, the residue concentration in milk fat was approximately 0.4 that in depot fats. PBB had a
predilection for lipid tissues with similar concentrations in various depot fats. Concentrations of the
residue were notably low in tissues of the nervous system despite the high content of lipid material. Liver
contained residue concentrations that were disproportionately high when compared to the lipid content of
the organ. Calves born to PBB-exposed cows had similar distribution of residues in body tissues although
concentrations were less than those of the dam.
Introduction
An understanding of the distribution and clear-
ance of xenobiotic residues in food producing ani-
mals is critical for evaluation of possible subacute
toxic effects on exposed animals and subsequent
transmission of the residue to man. This informa-
tion is vital for the interpretation of residue con-
centrations in samples ofbody tissues or excretions
used to regulate the exclusion of animals and/or
food from marketing channels.
Development of most of the information on dis-
tribution and clearance of polybrominated
biphenyls (PBB) was necessitated by the impact of
inadvertent mixing of FireMaster, a commercial
flame retardant, into cattle feed (/). This accident
resulted in exposures to animals that have varied
greatly in amount and duration. A variety of
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nonspecific toxic responses were reported by cattle
accidentally exposed to high concentrations of the
flame retardant (2). Claims that many of the same
toxic symptoms have occurred in cattle exposed to
very low levels of PBB have been made but could
not be verified by a field study (3). An understand-
ing of the distribution and clearance of FireMaster
at acutely toxic levels and below was necessary to
understand toxic responses and to aid the estab-
lishment of regulatory tolerance levels in food pro-
ducing animals. Like commercial preparations of
polychlorinated biphenyls (PCB), the PBB in Fire-
Master consists of a mixture of halogenated
biphenyls (4). By analogy to PCB, each of these
specific brominated biphenyls may behave differ-
ently in vivo. Studies with PCB have shown that the
number of chlorines generally affects absorption
(5), excretion (6), and toxicity (7). However, the
behavior and toxicity ofsome chlorinated biphenyls
is influenced by chlorine position on the biphenyl in
addition to the halogen content (8). An understand-
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biphenyls in FireMaster was needed.
This paper reports an overview of several ex-
periments conducted over a three year period de-
signed to elucidate mechanisms of clearance and
toxicity of polybrominated biphenyls in dairy cows
and calves.
Methods and Materials
Animals
Sixty dairy animals have been involved in seven
studies to determine the distribution, clearance, and
health effects of FireMaster BP-6. The protocol for
these experiments with cows, heifers, and calves
are in Table 1. Detailed descriptions of methods
used for experiments: 1, 2, 3 (9); 4 (10); and 7 (11)
have been reported.
Experiments 1, 2, and 3 were designed to care-
fully monitor the short-term distribution and clear-
ance of FireMaster. In these studies close interval
sampling ofblood and excreta, complete collections
ofexcreta, inert plus radiolabeled tracers, and nec-
ropsies were employed to determine the fate of the
residue. Experiment 4 provided information on
residue distribution when from 0 to 25 g was given
for 60 days to pregnant heifers. Samples of blood,
body fat, and excreta were collected frequently
throughout the dosing period and currently extends
beyond the second parturition for many of these
animals. In order to determine the distribution of
PBB in 35 tissues, animals from each group were
allotted for necropsy immediately following the
Table 1. Protocol for seven experiments on the distribution and effects of PBB on dairy cattle.
PBB exposure
Total dose to Post
Daily body weight exposure
amount, Duration, ratio, study,
Experiment Animals Statusa mg days mg/kg BW days
lb I Cow P L 3000 1 4.59 l lOOe
I Cow P L N 3000 1 5.95 10
2b I Calf N 0.54 44 0.78
I Calf N d 95 44
3c I Calf N 25,000 9 5000
4c 2 Heifers P N 0 60 0
1 Heifer P L N 0 60 0 170
3 Heifers P L 0 60 0 640e
2 Heifers P N 0.25 60 0.0375
1 Heifer P L N 0.25 60 0.0375 170
3 Heifers P L 0.25 60 0.0375 640"
2 Heifers P N 250 60 37.5
1 Heifer P L N 250 60 37.5 170
3 Heifers P L 250 60 37.5 640"
6 Heifers P N 25,000 32-60Mf 2650 -
5 3 Calves 9 160 475e
I Calf N " 160 10
3 Calves h 160 475"
1 Calf N h 160 10
3 Calves 160 475e
I Calf N 160 10
6 1 Heifer P L 250 180 90.0 500Y
S Heifers P 0 202 0 200"
4 Heifers P 250 202 100 200"
7c 2 Cows N 25,000 25 1470 35
2 Cows N 0 25 0 35
a During course of experiment animals were: P = Pregnant; L = Lactating N = Necropsied.
b Lot 158RP of FireMaster BP-6 was used.
c Lot 6244A of FireMaster BP-6 was used.
d Calf from experiment 1.
e Under continued observation-days as of 10-1-1977.
' All animals moribund between days 33 and 66.
9 Calves from experiment 4, 0.0 mg/day heifers.
h Calves from experiment 4, 0.25 mg/day heifers.
i Calves from experiment 4, 250 mg/day heifers.
Environmental Health Perspectivesdosing period and 10 days postpartum. All
moribund animals were also necropsied. In experi-
ment 5, the residue concentrations in calves from
experiment 4 have been studied.
Experiments 6 and 7 were designed as toxicity
studies; however, additional information on residue
dynamics was obtained from blood, body fat, and
excreta samples.
Doses of FireMaster were administered to ani-
mals in gelatin capsules with balling guns in order to
insure complete consumption of the residue and
minimize cross-contamination. Separate equipment
was used for handling and management of experi-
mental groups in order to further reduce chances of
cross contamination.
Analyses
The procedures used for the analysis of PBB in
this laboratory have previously been reported in
considerable detail (9, 12). In experiments 1, 2, and
3 only the major hexabromobiphenyl (peak 3, Fig.
1) was quantitated. The position ofthe bromines on
this biphenyl have been identified as 2,2',4,4',5,5'
(4, 13). In experiments 4 through 7 all six peaks
(Fig. 1) were quantitated, although chromato-
graphic conditions were optimized for peak 3. Un-
fortunately peak 1 could not be accurately quanti-
tated in all samples: therefore, all data for this peak
has been omitted from this paper. Peaks 1 and 2
have been identified as pentabromobiphenyls,
peaks 4 and 5 as hexabromobiphenyls, and peak 6
as heptabromobiphenyl (4). Hereafter the compo-
nents of the mixture (Fig. 1) will be referred to as:
peak 2, PtBB2; peak 3, HBB3; peak 4, HBB4; peak
5, HBB5; and peak 6, HpBB6.
Results and Discussion
The two lots of FireMaster BP-6 used in our
studies, 158-RP and 6244A, differed slightly in the
relative concentration of the brominated biphenyls
(9). These differences were minor and probably
have no significant effect on interpretation of the
kinetics of PBB. In the studies in which lot 158-RP
was used only HBB3 was quantitated. Since HBB3
represented greater than 60% oflot 6244A, primary
emphasis has been placed on determining the con-
centration and kinetics of this component of Fire-
Master in tissues and excretions of cattle.
The minor brominated biphenyls of the mixture,
having varying halogen content and/or position,
provide valuable insight into the kinetics of PBB in
cattle. Therefore, quantitation ofthese components
was made, although GLC conditions were op-
timized for HBB3. The minor components were not
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FIGURE 1. Gas-liquid chromatographic separation of the major
brominated biphenyls in FireMaster BP-6. Conditions for the
H. P. 5736 with 63Ni detectors were: 0.5 m column of 5%
OV-17 on Gas-Chrom Q, with column temperature at 270°C
and argon: methane (95:5) as carrier and purge. Halogen
content of peaks 1 and 2 (penta), 3 through 5 (hexa), and 6
(hepta) have been reported (1).
quantitated as parts per million of that compound
because they comprised minor quantities of a com-
mercial compound which still has not been fully
identified. Changes in vivo ofinert, nonhalogenated
biphenyl or otherbiphenyl components could cause
profound errors in reported concentrations ofthese
minor components. In order to minimize these er-
rors, yet quantitate the behavior of the minor com-
ponents, samples from experimental animals were
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69quantitated against a standard of FireMaster BP-6
(lot 6244A) in which the concentration ofeach com-
ponent was assigned the value of 1. Thus absolute
concentration could not be determined, but the rel-
ative concentration of each component could.
PBB Concentrations in Feces
When FireMaster BP-6 was fed to dairy animals,
feces was clearly the most important excretory
pathway during exposure. The rate of passage of
unconjugated PBB through the gastrointestinal (GI)
tract was much the same as the flow of alimentary
contents. The appearance and decline of HBB3 in
feces of animals given single 3-g doses of Fire-
Master were significantly correlated with passage of
a chromic oxide (Cr203) marker (9). Presence of
both PBB and Cr2O3 were detected in feces ap-
proximately 12 hr after administration, reached
peak concentrations between 20 and 36 hr after
dosing, then declined to about 2% of peak concen-
tration during the subsequent 48 hr. Approximately
halfofeach single dose administered was accounta-
ble in feces by day 8 (9).
The concentration of HBB3 in feces ofheifers fed
250 mg/day ofBP-6 for 60 days reached steady state
by day 10. Following withdrawal of the PBB the
concentration of HBB3 declined, and in 10 days had
decreased to approximately 1% ofthe concentration
present during exposure.
Following the initial decline, the residue concen-
tration in feces remained stable until parturition.
Total collections offeces were not made during this
period so daily excretion can only be estimated.
However, assuming 20 kg of fecal output daily,
these animals were clearing only 0.7 mg ofunconju-
gated HBB3 daily.
In experiments in which heifers were given 250
mg of FireMaster for 202 days, concentrations of
HBB:, in feces during exposure were virtually iden-
tical to animals given the same daily dose for 60
days. Presently, direct relationships between the
amount of PBB fed and fecal concentration cannot
be made. The animals given 25 g daily displayed
toxic effects which included diarrhea, anorexia, and
dehydration (12). Concentrations ofPBB in samples
offeces from these animals sometimes were greater
than 40,000 ppm. In contrast, PBB concentrations
in feces from heifers receiving 0.25 mg daily were
often at or below the sensitivity limit ofour analyti-
cal procedures (14).
Few studies with PBB have reported fecal excre-
tion. Detering et al. (15)-and Cook et al. (16) studied
cows that had been environmentally contaminated
(2) 7-9 months prior to study. The authors esti-
mated exposures of between 200 and 400 g of PBB
over a 2-week period. Concentration of PBB in
feces at the time of their study averaged 0.22 ppm
with a daily excretion of 10 mg. Animals in our
studies which received similar daily doses of PBB
became moribund during the dosing period, and
thus post-exposure clearance was not determined.
Animals that received 250 mg daily had PBB con-
centration ratios in body fat to feces ofabout 750:1,
which correspond with ratios reported for these en-
vironmentally exposed animals (15); however, the
feces to plasma ratio of0.7:1 in our studies does not
correspond with reported ratios of4.2:1 (16).
Free (unconjugated) residues of PBB have not
been detected in urine of cows in our experiments.
This route ofexcretion must not be overlooked as a
possible route ofclearance of minor or metabolized
brominated biphenyls. For that matter, hy-
droxylated, conjugated, or otherwise bound PBB
may escape detection in feces. During our initial
study a '4C-labeled tetrachlorobiphenyl was used as
a tracer compound and administered with the Fire-
Master BP-6 (9). Total radioactivity accumulated in
urine accounted for 24.4.% of the 14C dose, none of
which was ether-extractable.
Although a-large proportion of '4C from the PCB
with four halogens was recovered, presumably in
conjugated form, this route still may be of little im-
portance in PBB exposed cows. Most of the major
biphenyls in FireMaster contain five or more halo-
gens, thus reducing the chances of metabolism and
excretion (5). Further, if HBB3 were efficiently
conjugated and excreted it would not be likely that
tissue PBB concentrations would persist as have
been observed in our studies.
Whereas feces was the most important excretory
route in nonlactating animals, milk became the
major route in lactating animals. Animals that pre-
viously received 250 mg/day for 60 days had a clear-
ance of PBB via milk that was three times that in
feces. This clearance in milk was only about 2 mg/
day.
When FireMaster was fed to lactating cows,
HBB3 was detected in milk 13 hr post-exposure (9),
and milk concentrations were stable by 20 days (19).
Upon withdrawal of the PBB source, Fries and
Marrow (19) reported a 71% decline in the concen-
tration of HBB3 in milk fat within 15 days, and
thereafter the decline had a half-life of 58 days.
Animals in our studies exposed to PBB prior to
parturition exhibited similar initial declines in milk
residue concentrations postpartum. Perhaps ac-
cumulations of PBB in the mammary tissue may
have contributed to these initially high concentra-
tions. Thereafter, the reported 58 day half-life does
not agree with our data. During peak lactation,
when our experimental animals were metabolizing
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fat and again declined when animals were gaining
weight. Whereas the estimate of a 58 day half-life
may be applicable for animals not changing weight,
a more complex model is necessary to describe
excretion of PBB in milk throughout a complete
lactation.
PBB Concentrations in Tissues
Understanding the transfer of PBB to and from
plasma is critical to an evaluation of distribution,
clearance, and potential target organ toxicity. Fol-
lowing administration of FireMaster to dairy cattle,
the major brominated biphenyls were readily ab-
sorbed from the GI tract and were detectable in
plasma within 2-4 hr. In single-dose experiments,
the concentration in blood plasma was maximal 24
hr after exposure. When multiple doses were ad-
ministered, plasma concentrations were at equilib-
rium by 15 days. The concentration of HBB: was
remarkably constant among animals when fed 250
mg PBB daily for 60 or 202 days. Average plasma
concentrations of HBB:, were about 0. 13 ppm.
When dosing with FireMaster was terminated,
concentrations of HBB:, in plasma declined ap-
proximately 50% in 10 days and 66% by day 20.
Thereafter, plasma residues do not fit a consistent
decline model. To describe plasma changes in PBB
concentration among environmentally exposed
animals mathematically is difficult to achieve with
accuracy. Changes in plasma concentrations of
HBB:1 among experimentally exposed animals have
indicated that corrections for pregnancy, lactation,
and body weight (fat) changes will be necessary.
Table 2 shows mean concentrations of HBB3 in
plasma and major tissue groups of heifers and their
calves that were necropsied when moribund, at the
end of PBB exposure, or 10 days postpartum. Tis-
sue:plasma residue concentration ratios are also
presented. The relative tissue concentrations in
various tissues were not unlike those found in ne-
cropsied tissues of cows and calves environmen-
tally and experimentally exposed to PBB (9, 17, 18).
Basically PBB has a strong predilection for fatty
tissues with the notable exception of tissues of the
nervous system. Whether the latter effect reflects
failure of the residue to cross the blood brain barrier
or simply reflects the inability ofPBB to accumulate
in the phospholipids, glycolipids, and sulfolipids of
nervous tissues has not been demonstrated.
Most of the tissues of the body will fit nicely into
one of the five tissue groupings in Table 2 having
similar concentrations of extractable lipids and
therefore similar PBB content. Bile, liver, and
mammary tissues would not fit these categories, as
they contained disproportionately large residue
concentrations.
Where residue concentrations were above the
limits of analytical sensitivity, the tissue:plasma
ratios were remarkably consistent for nervous tis-
sues (spinal cord, pons, and cortex) contractile tis-
sues (smooth, striated, and cardiac) and liquid tis-
sue (allantoic, amniotic, CSF, and synovial). This
relationship probably represents an equilibrium
between blood and the liquid tissues. However, it is
Table 2. Mean concentrations of hexabromobiphenyl in tissue groups and the ratios of tissue/plasma.
Exposure, Necropsy 2,2',4,4',5,5'-hexabromobiphenyl in tissue, ppm
Animals g day Plasma Fats Nervous Contractiles Glands Liver Liquids Bile
6 Heifers 1125 33-66 Mean 53.3 1836 73.2 57.3 236 267 2.0200 53.3
T/P Ratio 1.0 102 4.1 3.2 13.1 14.8 0.1 3.0
2 Heifers 15 61 Mean 0.1368 25.3 0.641 0.524 1.246 3.999 0.0198 0.536
T/P Ratio 1.0 184 4.7 3.8 9.1 29.2 0.1 3.9
I Heifer 15 230 Mean 0.0461 26.0 0.085 0.179 1.107 3.164 0.0244 0.117
T/P Ratio 1.0 563 1.8 3.8 24.0 68.6 0.5 2.5
1 Calf " 10 Mean 0.0563 12.03 0.011 0.656 0.632 0.575 0.0112 0.061
T/P Ratio 1.0 213 4.1 11.6 11.2 10.2 0.2 1.1
2 Heifers 0.015 61 Mean 0.0026 0.163 Tr' 0.008 0.015 0.246 Tr Tr
T/P Ratio 1.0 62.7 - 3.2 5.6 94.6 -
I Heifer 0.015 230 Mean Tr 0.123 NDI' 0.015 0.011 0.063 Tr Tr
T/P Ratio
I Calf b 10 Mean Tr Tr ND Tr Tr 0.030 Tr ND
T/P Ratio
a Exposure by placental transport from preceeding dam plus 18.4 mg from dam's milk.
bExposure by placental transport from preceeding dam plus .24 mg from dam's milk.
'Trace.
"None detected.
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nervous or contractile tissues and the blood or
whether the constancy simply reflects bound res-
idue resulting from the initial exposure.
The grouping of 10 glandular tissues (adrenal,
spleen, pancreas, kidney, thymus, thyroid, ovaries,
parotid, lymphatic, and lung) (Table 2) was the most
heterogenous group. Due to the widely varied func-
tion of each of these organs the residue accumula-
tion of each merits further study.
High concentrations of PBB in liver tissue were
not surprising in light of the detoxification and
excretion functions of the liver. Among the animals
directly exposed to the residue, greater efficiency of
accumulation ofHBB:, at avery low level was clearly
evident, particularly in liver. Ratios of the residue
concentration in liver or fat tissue to the total dose
consumed by the animals were calculated. Expo-
sures of 25 g and 250 mg/daily resulted in liver:total
exposure ratios ofapproximately 0.25. The ratio was
17 for heifers in the 0.25 mg daily feeding group.
While not as pronounced as in liver, the accumula-
tion pattern in fatty tissues was similar, with ratios of
1.7 for the higher exposures and 10 for animals re-
ceiving 0.25 mg daily.
Excretion in bile was probably the major source
ofPBB in feces following withdrawal ofthe residue.
Unfortunately, the low numbers of samples of bile
obtainable and unknown daily bile production did
not allow quantitation of biliary excretion.
The concentrations of HBB3 in the various depot
fats of the body were quite similar. Within animals
receiving the same exposure, the coefficient ofvari-
ation was approximately 25%. Subcutaneous fats
appeared to be the most variable, and concentra-
tions in this pool were particularly affected by body
weight changes of animals.
Figure 2 shows the HBB3 concentrations in sub-
cutaneous fat samples of animals given 0, 0.25, and
250 mg for 60 days or 25 g until moribund. This
figure clearly shows the biomagnification or con-
centration of residues in fatty tissues of animals in
contact with very small amounts ofPBB. By design,
to obtain the toxicological data for this experiment,
all animals were housed in the same facility. Despite
a meticulously designed protocol to minimize
cross-contamination, the animals not experimen-
tally exposed to BP-6 accumulated detectable con-
centrations in body fat. Based on tissue concentra-
tions observed in animals receiving 0.25 mg daily (a
total of 15 mg), we estimate that the experimentally
unexposed animals consumed approximately 7 mg.
Considering that more than 3 million mg were ex-
creted in the facility by other animals, the experi-
mental protocol appeared very successful.
Animals given 25 g daily lost weight, became
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FIGURE 2. Average concentrations of hexabrominated biphenyl
(HBB3) in samples of subcutaneous fat from heifers given
daily doses ofFireMaster BP-6 for 60 days or until moribund.
(s) 0; (A) 2.5 x 10-' mg/day; (o) 2.5 x 102 mg/day; (.)2.5 x
104 mg/day.
moribund, and were necropsied with 33 to 66 days
(10, 14). Concentrations ofHBB3 in subcutaneousfat
from these animals ranged from 1100 to 6000 ppm.
Among animals given 0.25 or 250 mg daily there
was a 40% decline in HBB3 by 20 days post expo-
sure (Fig. 2). Fat samples were not again collected
until parturition, when an increase in the residue
concentration had occurred. The concentration in
subcutaneous fat continued to increase during
heavy lactation when the animals were mobilizing
depot fats. Biopsies were again collected in late
lactation, and significant declines in residue con-
centrations had occurred. The latter effect probably
reflects the redeposition of subcutaneous fat and a
reduced body burden of PBB resulting from excre-
tion of the residue in milk.
Distribution of Minor Components of
FireMaster
The quantities of hydrocarbon represented by
the minor penta-, hexa-, and heptabrominated
biphenyls in FireMaster are quite small. In order to
understand the significance ofeach ofthese compo-
nents when accumulated in the mammalian system,
additional studies will be needed. The positive
identification ofeach biphenyl is especially needed.
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nents and less than ideal conditions for quantitation,
a comparison of the relative concentrations of the
minor biphenyls has provided insight into the be-
havior of PBB in vivo. The best comparisons of
concentrations for the minor peaks were obtained
from samples from heifers given 250 mg/day of
FireMaster.
During the period when doses were being ad-
.ministered the relative concentration of penta-
brominated biphenyl (PtBB2) in feces was de-
creased by about 45% and elevated in plasma ap-
proximately 50%. It was also slightly elevated in
bile ofthe two necropsied animals. At the same time
the relative proportion ofheptabrominated biphenyl
HpBB6 in feces was elevated approximately 15%
compared to the FireMaster standard. HpBB6 was
proportionately decreased in plasma and bile by 50
and 80%.
Ten days after the last dose was given and the
concentration of all of the FireMaster components
had declined, the relative concentrations of each
had changed. The relative concentration of PtBB2
increased sharply, nearly doubling in feces and
plasma; HpBB6 declined by 45 and 90%, respec-
tively. Following initiation of lactation, very high
relative concentrations of PtBB2 were detected in
milk fat, and the HpBB3 was virtually undetectable.
These relationships indicated that bromine con-
tent influenced the absorption of PBB from the gut
and subsequent transfer from plasma to depot fat.
The pentabrominated compound was apparently
more efficiently absorbed during feeding and ob-
tained equilibrium between plasma and tissues at a
higher relative concentration than found in the
FireMaster that was fed to the animals. The oppo-
site occurred with the heptabrominated biphenyl as
a large proportion was apparently excreted in feces
during the dosing period. Changes in the accumula-
tion and excretion of the minor hexabrominated
biphenyls also occurred; however, these differences
cannot be easily explained without positive identifi-
cation of the bromine position. The position of the
halogen on the biphenyl has been shown to influ-
ence the distribution and clearance of polychlori-
nated biphenyls (5).
Although these relationships have suggested an
effect on halogen content absorption of PBB, the
possibility of biotransformation or degradation of
one or more components of FireMaster cannot be
ruled out. Transformations could greatly alter the
relative concentrations of minor components.
General Discussion
These studies have provided pertinent informa-
tion on the distribution and clearance ofthe compo-
nents ofFireMaster when dose levels and durations
were varied. Animals from nearly all stages of
productive life have been utilized. The data from
these studies are being used to develop phar-
macokinetic models which can be used to predict
the behavior of PBB residues in environmentally
contaminated livestock. The variety of protocols
used for these studies provided data that have
clearly demonstrated the simple kinetic models are
inadequate to describe the long term behavior of
this residual compound in dairy cows. The data
from these studies has demonstrated that growth,
fat deposition, fat mobilization, lactation, preg-
nancy, and level ofexposure have important effects
on the kinetics ofPBB in cows. The true behavior of
FireMaster in vivo is further complicated by the
nature of the compound. Since it comprises of a
mixture of compounds with differing halogen con-
tent and positional isomers, each component has a
different biological behavior.
Surprisingly high concentrations of PBB can be
accumulated in tissues of cows without apparent
signs of toxicity (10, 14, 20). Claims that PBB
causes toxic responses and death among dairy ani-
mals environmentally contaminated with trace
levels of the compound must be seriously ques-
tioned, as we still have healthy animals on experi-
ment with PBB concentrations up to and exceeding
30 ppm. Along with the information on the distribu-
tion of PBB in cattle, we have developed a broad
base of information on the clinical (9, 10, 20, 21),
pathological (14, 22), and target organ (11, 23) ef-
fects of exposed animals. These studies are con-
tinuing to develop a data base ofresidue and clinical
information for the lifetime of remaining experi-
mental animals.
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